Isofol Announces its Intention to Carry Out a Fully Guaranteed Preferential Rights Issue of Approximately SEK 150 Million and a Potential Over-allotment Option of up to Approximately SEK 30 Million

GOTHENBURG, Sweden, March 30, 2020 /PRNewswire/ — Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), today announced that the Board has the intention to carry out a rights issue of approximately SEK 150 million with preferential rights for the Company’s…

About the Author

has written 20650 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com